Raedun Clarke

857 total citations
17 papers, 421 citations indexed

About

Raedun Clarke is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Raedun Clarke has authored 17 papers receiving a total of 421 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Immunology. Recurrent topics in Raedun Clarke's work include CAR-T cell therapy research (10 papers), CRISPR and Genetic Engineering (7 papers) and Immune Cell Function and Interaction (6 papers). Raedun Clarke is often cited by papers focused on CAR-T cell therapy research (10 papers), CRISPR and Genetic Engineering (7 papers) and Immune Cell Function and Interaction (6 papers). Raedun Clarke collaborates with scholars based in United States, Canada and Netherlands. Raedun Clarke's co-authors include Gordon Keller, Terry A. Potter, Amanda D. Yzaguirre, Nancy A. Speck, Antoine Bondue, Yumi Yashiro–Ohtani, Cédric Blanpain, Warren S. Pear, Yosef Refaeli and Brian C. Turner and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Nature Biotechnology.

In The Last Decade

Raedun Clarke

17 papers receiving 414 citations

Peers

Countries citing papers authored by Raedun Clarke

Since Specialization

Citations

This map shows the geographic impact of Raedun Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raedun Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raedun Clarke more than expected).

Fields of papers citing papers by Raedun Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raedun Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raedun Clarke. The network helps show where Raedun Clarke may publish in the future.

Co-authorship network of co-authors of Raedun Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Raedun Clarke. A scholar is included among the top collaborators of Raedun Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raedun Clarke. Raedun Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Abstract 3618: High-avidity BCMA CAR and high-affinity, non-cleavable CD16 Fc receptor incorporated in off-the-shelf CAR T cells promote multi-antigen targeting and durable anti-tumor cytotoxicity in the treatment of multiple myeloma 2024 ·Cancer Research ·(unknown), (unknown), Bryan Hancock, (unknown), Brian Groff, (unknown), (unknown), (unknown), Yijia Pan, Alex Garcia, (unknown), Matthew Denholtz, Tom Lee, Ramzey Abujarour, Ryan Bjordahl, Armin Rehm, Raedun Clarke, Jode Goodridge, Bahram Valamehr	1
2	Generation of T-cell-receptor-negative CD8αβ-positive CAR T cells from T-cell-derived induced pluripotent stem cells 2022 ·Nature Biomedical Engineering ·Sjoukje J. C. van der Stegen, (unknown), Roseanna M. Petrovic, Hongyao Xie, (unknown), Vera Alexeeva, Yuzhe Shi, Jorge Mansilla‐Soto, Mohamad Hamieh, Justin Eyquem, Annalisa Cabriolu, Xiuyan Wang, Ramzey Abujarour, Tom T. Lee, Raedun Clarke, Bahram Valamehr, Maria Themeli, Isabelle Rivière, Michel Sadelain	49
3	Alloimmune Defense Receptor Harnesses Host Immune Cell Activation to Potentiate Functional Persistence and Anti-Tumor Activity of Off-the-Shelf, Cell-Based Cancer Therapy 2022 ·Blood ·(unknown), (unknown), Yijia Pan, Brian Groff, Rina M. Mbofung, (unknown), Christine Chen, Lauren Fong, Nicholas Brookhouser, Berhan Mandefro, Ramzey Abujarour, Tom Lee, Maksim Mamonkin, Raedun Clarke, Ryan Bjordahl, Jode Goodridge, Bahram Valamehr	7
4	High-Density Cryopreservation of Off-the-Shelf CAR-NK Cells Facilitates On-demand Treatment Access 2022 ·Blood ·Ya‐Ju Chang, Niancao Chen, Christine Chen, Tingxia Guo, (unknown), Svetlana Gaidarova, Bryan Hancock, Betsy Rezner, (unknown), Mark Plavsic, Richard A. Anderson, Raedun Clarke, Bahram Valamehr	1
5	NOTCH and CAR Signaling Control T Cell Lineage Commitment from Pluripotent Stem Cells 2020 ·Blood ·(unknown), (unknown), Roseanna M. Petrovic, Benjamin M. Whitlock, Raedun Clarke, Bahram Valamehr, Isabelle Rivière, Michel Sadelain	2
6	Abstract 3576: FT500, an off-the-shelf NK cell cancer immunotherapy derived from a master pluripotent cell line, enhances T-cell activation and recruitment to overcome checkpoint blockade resistance 2018 ·Cancer Research ·Ryan Bjordahl, Sajid Mahmood, Svetlana Gaidarova, Ramzey Abujarour, Raedun Clarke, (unknown), Paul Rogers, Moyar Ge, Megan Robinson, Betsy Rezner, Tom Tong Lee, Bahram Valamehr	7
7	Abstract LB-108: Generation of off-the-shelf TCR-less CAR-targeted cytotoxic T cells from renewable pluripotent cells for cancer immunotherapy 2018 ·Cancer Research ·Raedun Clarke, (unknown), Tom Lee, Jorge Mansilla‐Soto, Chia‐Wei Chang, (unknown), (unknown), Eigen Peralta, Ian R. Hardy, (unknown), Isabelle Rivière, Michel Sadelain, Bahram Valamehr	9
8	Generation of Clonal Antigen Specific CD8αβ+ Cytotoxic T Lymphocytes from Renewable Pluripotent Stem Cells for Off-the-Shelf T Cell Therapeutics 2017 ·Blood ·(unknown), Raedun Clarke, (unknown), (unknown), Chia‐Wei Chang, (unknown), Tom Lee, Weijie Lan, Daniel Shoemaker, Isabelle Rivière, Bahram Valamehr, Michel Sadelain	1
9	Multi-Functional Genetic Engineering of Pluripotent Cell Lines for Universal Off-the-Shelf Natural Killer Cell Cancer Immunotherapy 2017 ·Blood ·Ryan Bjordahl, Raedun Clarke, Svetlana Gaidarova, (unknown), (unknown), Brian Groff, Tom Lee, Weijie Lan, Ramzey Abujarour, Greg Bonello, Megan Robinson, Ian R. Hardy, Daniel Shoemaker, Bahram Valamehr	1
10	Genetically Enhanced Pluripotent Stem Cell-Derived T Lymphocytes for Off-the-Shelf Cellular Immunotherapy 2016 ·Blood ·Raedun Clarke, Brian Groff, (unknown), (unknown), Tom Tong Lee, Weijie Lan, Michelle Burrascano, Ramzey Abujarour, Greg Bonello, Megan Robinson, Heather Foster, David Robbins, (unknown), Daniel Shoemaker, Stewart Abbot, Bahram Valamehr	1
11	A Quantitative Proteomic Analysis of Hemogenic Endothelium Reveals Differential Regulation of Hematopoiesis by SOX17 2015 ·Stem Cell Reports ·Raedun Clarke, Aaron M. Robitaille, Randall T. Moon, Gordon Keller	10
12	Defining the path to hematopoietic stem cells 2013 ·Nature Biotechnology ·Christopher M. Sturgeon, Andrea Ditadi, Raedun Clarke, Gordon Keller	36
13	The expression of Sox17 identifies and regulates haemogenic endothelium 2013 ·Nature Cell Biology ·Raedun Clarke, Amanda D. Yzaguirre, Yumi Yashiro–Ohtani, Antoine Bondue, Cédric Blanpain, Warren S. Pear, Nancy A. Speck, Gordon Keller	120
14	Temporal specification of blood progenitors from mouse embryonic stem cells and induced pluripotent stem cells 2010 ·Development ·Stefan Irion, Raedun Clarke, Hervé Luche, Injune Kim, Sean J. Morrison, (unknown), Gordon Keller	58
15	A new function for LAT and CD8 during CD8‐mediated apoptosis that is independent of TCR signal transduction 2009 ·European Journal of Immunology ·Raedun Clarke, (unknown), Yosef Refaeli, Guy Werlen, Terry A. Potter	5
16	Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target 2008 ·Blood ·Ryan M. Young, Ian R. Hardy, Raedun Clarke, (unknown), Polly Pine, Brian C. Turner, Terry A. Potter, Yosef Refaeli	101
17	Ligation of CD8 leads to apoptosis of thymocytes that have not undergone positive selection 2004 ·Proceedings of the National Academy of Sciences ·Kristie M. Grebe, Raedun Clarke, Terry A. Potter	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact